ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria

被引:57
作者
Arcaro, G
Zenere, BM
Saggiani, F
Zenti, MG
Monauni, T
Lechi, A
Muggeo, M
Bonadonna, RC
机构
[1] Univ Verona, Sch Med, Azienda Osped Verona, Div Endocrinol & Metab Dis, I-37100 Verona, Italy
[2] Univ Verona, Sch Med, Azienda Osped Verona, Div Internal Med, I-37100 Verona, Italy
关键词
D O I
10.2337/diacare.22.9.1536
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - The purpose of this study was to test whether a short-course treatment with ACE inhibitors may restore endothelium-dependent and/or -independent vasodilation in the femoral artery of microalbuminuric patients with type 1 diabetes and normal arterial pressure. RESEARCH DESIGN AND METHODS - We studied nine normotensive microalbuminuric type 1 diabetic patients and two groups of control subjects matched for femoral artery diameter to type I diabetic patients after placebo (control group A, n = 17) and ACE inhibitor (control group B, n = 18) treatment, respectively. The patients were enrolled in a double-blind cross-over study with a 1-week trial of either placebo, captopril (25 mg t.i.d.), or enalapril (10 mg/day) in randomized order to ascertain whether short-term ACE inhibition obtained with (captopril) or without (enalapril) a sulfhydryl donor molecule ameliorates Vessel wall function. Endothelium-mediated Row-dependent vasodilation and endothelium-independent vasodilation were evaluated in the right common femoral artery by echo Doppler. RESULTS - Both captopril and enalapril normalized (control group B 22.9 +/- 3.2% per 8 min) endothelium-dependent response (19.6 +/- 7.5 and 18.0 +/- 5.3 vs. -10.4 +/- 4.1% per 8 min, P < 0.01, for both captopril and enalapril versus placebo, respectively) in the type I diabetic patients. Captopril (28.4 +/- 3.5 vs. 17.1 +/- 3.5%, per 5 min during placebo, P < 0.05) but not enalapril (20.1 +/- 3.0 vs. 31.7 +/- 2.8% per 5 min, P < 0.05 for enalapril Versus control group B, and NS for captopril vs. control group B) ameliorated endothelium-independent vasodilation in type 1 diabetic patients. CONCLUSIONS - ACE inhibition improves endothelium-dependent vasodilation in the femoral artery of normotensive microalbuminuric type 1 diabetic patients. Captopril also ameliorates endothelium-independent vasodilation, possibly through its sulfhydryl donor properties. These results may beef pathophysiological relevance to prevent cardiovascular complications in these patients.
引用
收藏
页码:1536 / 1542
页数:7
相关论文
共 39 条
[1]  
BADIMON L, 1992, J HYPERTENS S2, V10, P43
[2]   INHIBITION AND STIMULATION OF NITRIC-OXIDE SYNTHESIS IN THE HUMAN FOREARM ARTERIAL BED OF PATIENTS WITH INSULIN-DEPENDENT DIABETES [J].
CALVER, A ;
COLLIER, J ;
VALLANCE, P .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (06) :2548-2554
[3]   Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels [J].
Clarkson, P ;
Celermajer, DS ;
Donald, AE ;
Sampson, M ;
Sorensen, KE ;
Adams, M ;
Yue, DK ;
Betteridge, DJ ;
Deanfield, JE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (03) :573-579
[4]   PREJUNCTIONAL ANGIOTENSIN-II RECEPTORS - FACILITATION OF NOREPINEPHRINE RELEASE IN THE HUMAN FOREARM [J].
CLEMSON, B ;
GAUL, L ;
GUBIN, SS ;
CAMPSEY, DM ;
MCCONVILLE, J ;
NUSSBERGER, J ;
ZELIS, R .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (02) :684-691
[5]   MICROALBUMINURIA - IMPLICATIONS FOR MICROVASCULAR AND MACROVASCULAR DISEASE [J].
DECKERT, T ;
KOFOEDENEVOLDSEN, A ;
NORGAARD, K ;
BORCHJOHNSEN, K ;
FELDTRASMUSSEN, B ;
JENSEN, T .
DIABETES CARE, 1992, 15 (09) :1181-1191
[6]  
DRURY PL, 1984, DIABETOLOGIA, V27, P174
[7]   INHIBITION OF NITRIC-OXIDE SYNTHESIS IN FOREARM VASCULATURE OF INSULIN-DEPENDENT DIABETIC-PATIENTS - BLUNTED VASOCONSTRICTION IN PATIENTS WITH MICROALBUMINURIA [J].
ELLIOTT, TG ;
COCKCROFT, JR ;
GROOP, PH ;
VIBERTI, GC ;
RITTER, JM .
CLINICAL SCIENCE, 1993, 85 (06) :687-693
[8]   Preserved endothelial function in IDDM patients, but not in NIDDM patients, compared with healthy subjects [J].
Enderle, MD ;
Benda, N ;
Schmuelling, RM ;
Haering, HU ;
Pfohl, M .
DIABETES CARE, 1998, 21 (02) :271-277
[9]  
FELDTRASMUSSEN B, 1987, DIABETOLOGIA, V30, P610
[10]  
HAHN AW, 1990, CELL REGUL, V1, P640